Marie Le Bras

HMW Innovations AG, founded in 2002, helps investors benefit from German successful company sales of the MIG funds. The company is based in Pullach, Germany and has subsidiaries in Germany. The private company's description highlights their focus on sustainable innovation and invites potential investors to learn more about their offerings. The text is originally in German but has been translated to English.

HMW Emissionshaus AG is a German company that specializes in strategic asset building. The company is based in Pullach, Germany. The private company is the exclusive distributor of MIG funds and work with financial experts and investors to mobilize capital for sustainable investments and compelling return opportunities. The company's focus is on contributing to positive change.

APK AG provides recovery services of raw materials such as fossil fuels like oil, coal, gas, and renewable resources like plants. It also provides grinding and screening processes for hard rocks. The company was founded by Wolfgang Lindner in 2008 and is headquartered in Merseburg, Germany.

Onsight Ventures Management GmbH (Onsight Ventures) is a venture capital firm founded in 2021. The firm is headquartered in Innsbruck, Austria.

MIG Verwaltungs AG is a private equity investment firm headquartered in Munich, Germany. It was founded in 2004 by entrepreneurs and financial institutions, to follow up on the success of the venture capital investment vehicles Global Chance Fund and Global Asset Fund, with which MIG's management had been involved.

Tonestro is a music app that provides wind instrument lessons for individuals to learn and practice at home. The company is based in Pierbach, Austria. The app offers live feedback on rhythm and pitch while listening to the user play their instrument. The Austrian company was founded by Alexander Kogler, Christian Kapplmüller, Heinrich Huber, Christoph Huber, with Christoph Huber serving as CEO since its inception.

TRON - Translationale Onkologie an der Universitätsmedizin der is an independent biopharmaceutical non-profit translational research organization located in Mainz, Germany. TRON pursues new diagnostics and drugs for the treatment of cancer and other diseases with high medical need through their PhD Program. The German company was founded in 2010 by Ugur Sahin and the CEO is Michael Föhlings.

Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria.